Serum alkaline phosphatase isoenzyme profiles in phenobarbital-treated epileptic dogs

Veterinary Clinical Pathology

Volumn 33, Issue 4, 2004, Pages 215-222

  Gaskill, Cynthia L ^a   Hoffmann, Walter E ^b   Cribb, Alastair E ^a  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Alkaline phosphatase; Canine; Dog; Isoenzyme; Isoform; Phenobarbital

Indexed keywords

ALKALINE PHOSPHATASE; CELLULOSE ACETATE; CORTICOSTEROID; ISOENZYME; LECTIN; LEVAMISOLE; LIVER ENZYME; PHENOBARBITAL;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BIOLOGICAL MONITORING; BONE; CONTROLLED STUDY; DOG; ELECTROPHORESIS; ENZYME ACTIVITY; ENZYME ASSAY; EPILEPSY; EVALUATION; NONHUMAN; PRECIPITATION; PROSPECTIVE STUDY; WHEAT GERM;

CANIS FAMILIARIS; TRITICUM AESTIVUM;

EID: 12444311651     PISSN: 02756382     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-165X.2004.tb00376.x     Document Type: Article

References (45)

1. Boothe DM. Anticonvulsant therapy in small animals. Vet Clin North Am Small Anim Pract. 1998;28:411-448.
2. Podell M. Seizures in dogs. Vet Clin North Am Small Anim Pract. 1996;26:779-809.
3. Schwartz-Porsche D, Loscher W, Frey HH. Therapeutic efficacy of phenobarbital and primidone in canine epilepsy: a comparison. J Vet Pharmacol Ther. 1985;8:113-119.
4. Dayrell-Hart B, Steinberg SA, Van Winkle RJ, et al. Hepatotoxicity of phenobarbital in dogs: 18 cases (1985-1989). J Am Vet Med Assoc. 1991;199:1060-1066.
5. Center S. Pathophysiology, laboratory diagnostics, and diseases of the liver. In: Ettinger S, Feldman E, eds. Textbook of Veterinary Internal Medicine. Philadelphia, PA: WB Saunders Co; 1995:1261-1371.
6. Chauvet AE, Feldman EC, Kass PH. Effects of phenobarbital administration on results of serum biochemical analyses and adrenocortical function tests in epileptic dogs. J Am Vet Med Assoc. 1995;207:1305-1307.
7. Foster SF, Church DB, Watson ADJ. Effects of phenobarbitone on serum biochemical tests in dogs. Aust Vet J. 2001;78:23-26.
8. Gieger TL, Hosgood G, Taboada J, et al. Thyroid function and serum hepatic enzyme activity in dogs after phenobarbital administration. J Vet Intern Med. 2000;14:277-281.
9. Muller P, Taboada J, Hosgood G, et al. Effects of long-term phenobarbital treatment on the liver in dogs. J Vet Intern Med. 2000;14:165-171.
10. Balazs T, Farber TM, Feuer G. Drug-induced changes in serum alkaline phosphatase and alanine aminotransferase activities not related to hepatic injuries. Arch Toxicol Suppl. 1978;159-163.
11. Dowling P. Update on treatment of canine epilepsy. Can Vet J. 1999;40:595-598.
12. Sisson A. Current experiences with anticonvulsants in dogs and cats. In Proceedings of the 15th Annual Am Coll Vet Int Med Forum. Lake Buena Vista, FL; 1997:596-598.
13. Trepanier L. Using phenobarbital wisely. In Proceedings of the 17th Annu Am Coll Vet Int Med Forum. Chicago, IL; 1999:268-269.
14. Okey AB, Roberts EA, Harper PA, et al. Induction of drug-metabolizing enzymes: mechanisms and consequences. Clin Biochem. 1986;19:132-141.
15. Barter RA, Klaassen CD. Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP- glucuronosyltransferase inducers in rats. Toxicol Appl Pharmacol. 1994;128:9-17.
16. Hendrich S, Krueger SK, Chen HW, et al. Phenobarbital increases rat hepatic prostaglandin F2 alpha, glutathione S-transferase activity and oxidative stress. Prostaglandins Leukot Essent Fatty Adds. 1991;42:45-50.
17. Larsen MC, Jefcoate CR. Phenobarbital induction of CYP2B1, CYP2B2, and CYP3A1 in rat liver: genetic differences in a common regulatory mechanism. Arch Biochem Biophys. 1995;321:467-476.
18. Oguri K, Kurogi A, Yamabe K, et al. Purification of a phenobarbital-inducible UDP-glucuronosyltransferase isoform from dog liver which catalyzes morphine and testosterone glucuronidation. Arch Biochem Biophys. 1996;325:159-166.
19. Keller P. Enzyme activities in the dog: tissue analyses, plasma values, and intracellular distribution. Am J Vet Res. 1981;42:575-582.
20. Allen MJ, Hoffmann WE, Richardson DC, et al. Serum markers of bone metabolism in dogs. Am J Vet Res. 1998;59:250-254.
21. Hoffmann WE. Isoenzymes of alkaline phosphatase from liver and intestines of dogs and rabbits. In: Blackmore D, ed. Animal Clinical Biochemistry: The Future. Cambridge, UK: Cambridge University Press; 1988:181-187.
22. Kidney BA, Jackson ML. Diagnostic value of alkaline phosphatase isoenzyme separation by affinity electrophoresis in the dog. Can J Vet Res. 1988;52:106-110.
23. Sanecki RK, Hoffmann WE, Gelberg HB, et al. Subcellular location of corticosteroid-induced alkaline phosphatase in canine hepatocytes. Vet Pathol. 1987;24:296-301.
24. Sanecki R, Hoffmann WE, Hansen R, et al. Quantification of bone alkaline phosphatase in canine serum. Vet Clin Pathol. 1993;22:17-23.
25. Simon FR, Sutherland E. Hepatic alkaline phosphatase isoenzymes: isolation, characterization and differential alteration. Enzyme. 1977;22:80-90.
26. Syakalima M, Takiguchi M, Yasuda J, et al. Separation and quantification of corticosteroid-induced, bone and liver alkaline phosphatase isoenzymes in canine serum. Zentralbl Veterinarmed A. 1997;44:603-610.
27. Syakalima M, Takiguchi M. The canine alkaline phosphatases: a review of the isoenzymes in serum, analytical methods and their diagnostic application. Jpn J Vet Res. 1998;46:3-11.
28. Ehrhart N, Dernell WS, Hoffmann WE, et al. Prognostic importance of alkaline phosphatase activity in serum from dogs with appendicular osteosarcoma: 75 cases (1990-1996). J Am Vet Med Assoc. 1998;213:1002-1006.
29. Sanecki RK, Hoffmann WE, Dorner JL. Purification and comparison of corticosteroid-induced and intestinal isoenzymes of alkaline phosphatase in dogs. Am J Vet Res. 1990;51:1964-1968.
30. Solter PF, Hoffmann WE. Canine corticosteroid-induced alkaline phosphatase in serum was solubilized by phospholipase activity in vivo. Am J Physiol. 1995;269:G278-G286.
31. Unakami S, Komoda T, Watanabe M, et al. Molecular nature of three liver alkaline phosphatases detected by drug administration in vivo: differences between soluble and membranous enzymes. Comp Biochem Physiol B Biochem Mol Biol. 1987;88:111-118.
32. Sturtevant F, Hoffmann WE, Dorner J. The effect of three anticonvulsant drugs and ACTH on canine serum alkaline phosphatase. Vet Clin Pathol. 1977;13:754-757.
33. Ashworth B, Horn DB. Evidence of osteomalacia in an outpatient group of adult epileptics. Epilepsia. 1977;18:37-43.
34. Dymling JF, Lidgren L, Wollo A. Biochemical variables related to calcium metabolism in epileptics. Acta Med Scand. 1979;205:401-404.
35. Hunt PA, Wu-Chen ML, Handal NJ, et al. Bone disease induced by anticonvulsant therapy and treatment with calcitriol (1,25-dihydroxyvitamin D3). Am J Dis Child. 1986;140:715-718.
36. Pugh CB, Garnett WR. Current issues in the treatment of epilepsy. Clin Pharmacy. 1991;10:335-358.
37. Schmitt BP, Nordlund DJ, Rodgers LA. Prevalence or hypocalcemia and elevated serum alkaline phosphatase in patients receiving chronic anticonvulsant therapy. J Fam Pract. 1984;18:873-877.
38. Voudris K, Moustaki M, Zeis PM, et al. Alkaline phosphatase and its isoenzyme activity for the evaluation of bone metabolism in children receiving anticonvulsant monotherapy. Seizure. 2002;11:377-380.
39. Nijhawan R, Wierzbicki AS, Tozer R, et al. Antiepileptic drugs, hepatic enzyme induction and raised serum alkaline phosphatase isoenzymes. Int J Clin Pharmacol Res. 1990;10:319-323.
40. Gaskill CL, Burton SA, Gelens HCJ, et al. Effects of phenobarbital treatment on serum thyroxine and thyroid-stimulating hormone concentrations in epileptic dogs. J Am Vet Med Assoc. 1999;215:489-496.
41. Gaskill CL, Burton SA, Gelens HCJ, et al. Changes in serum thyroxine and thyroid-stimulating hormone concentrations in epileptic dogs receiving phenobarbital for one year. J Vet Pharmacol Ther. 2000;23:243-249.
42. Hoffmann WE, Sanecki RK, Dorner JL. A technique for automated quantification of canine glucocorticoid-induced isoenzyme of alkaline phosphatase. Vet Clin Pathol. 1988;17:66-70.
43. Deng JT, Hoylaerts MF, DeBroe ME, et al. Hydrolysis of membrane-bound liver alkaline phosphatase by GPI-PLD requires bile salts. Am J Physiol. 1996;271:G655-G663.
44. Solter PF, Hoffmann WE, Chambers M.D, et al. CCK-8 infusion increases plasma LMW alkaline phosphatase coincident with enterohepatic circulation of bile acids. Am J Physiol. 1997;273:G381-G388.
45. Solter PF, Hoffmann WE. Solubilization of liver alkaline phosphatase isoenzyme during cholestasis in dogs. Am J Vet Res. 1999;60:1010-1015.